Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hallucinogen persisting perceptual disorder: a scoping review covering frequency, risk factors, prevention, and treatment
Marcus A. Doyle, Susan Ling, Leanna M.W. Lui, et al.
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 6, pp. 733-743
Closed Access | Times Cited: 17

Showing 17 citing articles:

Psychedelics for the Treatment of Psychiatric Disorders: Interpreting and Translating Available Evidence and Guidance for Future Research
Roger S. McIntyre, Angela T.H. Kwan, Rodrigo B. Mansur, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 21-32
Closed Access | Times Cited: 2
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder
Joshua D. Rosenblat, M. Ishrat Husain, Yena Lee, et al.
The Canadian Journal of Psychiatry (2022) Vol. 68, Iss. 1, pp. 5-21
Open Access | Times Cited: 42
Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation
Gilly Wolf, Sandeep Singh, Karin Blakolmer, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 1, pp. 44-58
Closed Access | Times Cited: 38
Primum Non Nocere: The Onus to Characterize the Potential Harms of Psychedelic Treatment
Sharmin Ghaznavi, Jeremy N. Ruskin, Stephen J. Haggerty, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 47-53
Closed Access | Times Cited: 1
Informed Consent to Psychedelic-Assisted Psychotherapy: Ethical Considerations
Andrew G. Lee, Daniel Rosenbaum, Daniel Z. Buchman
The Canadian Journal of Psychiatry (2024) Vol. 69, Iss. 5, pp. 309-313
Open Access | Times Cited: 7
Experiential Training in Psychedelic‐Assisted Therapy: A Risk‐Benefit Analysis
Daniel Rosenbaum, Crystal Hare, Emma Hapke, et al.
The Hastings Center Report (2024) Vol. 54, Iss. 4, pp. 32-46
Open Access | Times Cited: 5
Psychedelic Drugs as Treatment Agents
Rachel Yehuda, Lauren Lepow, Philip A. Bonnano, et al.
Oxford University Press eBooks (2025), pp. 999-1024
Closed Access
Psychedelics for Substance Use Disorders: Updates for the Psychiatric Trainee
Lauren Wilseck, Preet Chatha, Lawrence Canale, et al.
American Journal of Psychiatry Residents Journal (2025) Vol. 20, Iss. 3, pp. 2-5
Open Access
Societal Trends and Opportunities in the Aftermath of the Nova Psychedelic Trance Rave, Through Lilla and Benjamin
Demian Halperin, Tal Bar On, Nir Tadmor, et al.
Future Humanities (2025) Vol. 3, Iss. 1
Open Access
Serotonin 5-HT 2B receptor agonism and valvular heart disease: implications for the development of psilocybin and related agents
Roger S. McIntyre
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 10, pp. 881-883
Open Access | Times Cited: 10
Is the psychedelic experience an essential aspect of the therapeutic effect of serotonergic psychedelics? Conceptual, discovery, development and implementation implications for psilocybin and related agents
Roger S. McIntyre
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 10, pp. 885-889
Open Access | Times Cited: 5
Substance use and risk of suicide among adults who sought mental health and addiction specialty services through a centralised intake process in Nova Scotia: a cross-sectional study
Matiwos Soboka, Sherry H. Stewart, Philip G. Tibbo, et al.
BMJ Open (2024) Vol. 14, Iss. 10, pp. e086487-e086487
Open Access | Times Cited: 1
Molecular insights into GPCR mechanisms for drugs of abuse
Omar B. Sánchez-Reyes, Gregory Zilberg, John D. McCorvy, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 9, pp. 105176-105176
Open Access | Times Cited: 3
Postakute Effekte von klassischen Psychedelika
Ricarda Evens, Tomislav Majić
Nervenheilkunde (2024) Vol. 43, Iss. 06, pp. 350-356
Closed Access
Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies
Michel Sabé, Adi Sulstarova, Alban Glangetas, et al.
Molecular Psychiatry (2024)
Open Access
Rychle působící antidepresiva -otázky a odpovědi
Otázky Libor Ustohal, Odpovědi Eliška Bartečková
Psychiatrie pro praxi (2023) Vol. 24, Iss. 1, pp. 48-50
Closed Access
Understanding psychosis
Tommy Williams, Pamela Rollings-Mazza
Nursing (2023) Vol. 53, Iss. 10, pp. 22-28
Open Access
Page 1

Scroll to top